NEUROCRINE BIOSCIENCES INC NBIX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1996-05-23
NEUROCRINE BIOSCIENCES INC insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| SHERWIN STEPHEN A | director | 2026-06-05 | Option exercise | 10,000 | $79.79 |
| SHERWIN STEPHEN A | director | 2026-06-05 | Sell | 7,883 | $163.81 |
| SHERWIN STEPHEN A | director | 2026-06-05 | Sell | 2,549 | $164.44 |
| SHERWIN STEPHEN A | director | 2026-06-05 | Sell | 6,896 | $165.79 |
| SHERWIN STEPHEN A | director | 2026-06-05 | Sell | 5,829 | $166.56 |
| SHERWIN STEPHEN A | director | 2026-06-05 | Sell | 1,843 | $167.31 |
| Onyia Jude | Chief Scientific Officer | 2026-06-05 | Gift | 2,441 | — |
| SHERWIN STEPHEN A | director | 2026-06-05 | Option exercise | 15,000 | $53.64 |
Source: SEC EDGAR filings · CIK 0000914475 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.